Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis

Tanizawa, Roberta Sandra da Silva; Zerbini, Maria Claudia Nogueira; Rosenfeld, Ricardo; Kumeda, Cristina Aiko; Azevedo, Raymundo Soares; Siqueira, Sheila Aparecida Coelho; Velloso, Elvira Deolinda Rodrigues Pereira.
Rev. bras. hematol. hemoter ; 39(1): 4-12, Jan.-Mar. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-843954

Documentos relacionados

  1. Study identifies risk factors that may lead to secondary cancers.
  2. Origin and outcome of metastatic tumours to the testes: a nationwide study.
  3. Risk of a second cancer and infection in patients with indolent B-cell lymphoma exposed to first-line bendamustine plus rituximab: A retrospective analysis of an administrative claims database.
  4. Therapy-related myeloid neoplasms with different latencies: a detailed clinicopathologic analysis.
  5. Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.
  6. Second primary cancer among 217702 colorectal cancer survivors: An analysis of national German cancer registry data.
  7. Left-Side Contrast-Injection-Induced Pseudopathologic Vertebral Enhancement in Oncology Patients without Venous Obstruction: A Report of Two Cases.
  8. The risk of cancer following high, and very high, doses of ionising radiation.
  9. Second Malignant Neoplasms Following Treatment for Hepatoblastoma: An International Report and Review of the Literature.
  10. Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasms.